— Know what they know.
Not Investment Advice

ACAD NASDAQ

ACADIA Pharmaceuticals Inc.
1W: -3.5% 1M: -4.1% 3M: -11.1% YTD: -18.9% 1Y: -1.7% 3Y: -2.6% 5Y: -2.1%
$21.10
-0.22 (-1.03%)
 
Weekly Expected Move ±4.8%
$19 $20 $21 $22 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 37 · $3.6B mcap · 169M float · 1.13% daily turnover · Short 44% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
52.7 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 57.4%  ·  5Y Avg: -93.0%
Cost Advantage
59
Intangibles
38
Switching Cost
78
Network Effect
52
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ACAD shows a Weak competitive edge (52.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 57.4% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$31
Avg Target
$33
High
Based on 16 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 26Hold: 10Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$31.00
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-02 William Blair Initiated $29 +27.1% $22.81
2026-02-23 Wolfe Research Rudy Li Initiated $33 +33.4% $24.73
2026-02-23 Mizuho Securities $29 $35 +6 +45.9% $23.99
2026-02-03 RBC Capital $21 $31 +10 +18.6% $26.13
2026-01-06 UBS Ashwani Verma $35 $40 +5 +50.0% $26.66
2026-01-05 Needham $32 $34 +2 +29.3% $26.29
2025-12-16 Stifel Nicolaus $25 $37 +12 +35.7% $27.27
2025-12-15 H.C. Wainwright $32 $37 +5 +37.0% $27.00
2025-12-11 Stifel Nicolaus Paul Matteis $20 $25 +5 -6.8% $26.81
2025-12-04 UBS Ashwani Verma $39 $35 -4 +33.5% $26.22
2025-12-02 Mizuho Securities $21 $29 +8 +16.7% $24.85
2025-09-25 Deutsche Bank $62 $29 -33 +36.7% $21.21
2025-09-09 UBS $36 $39 +3 +57.0% $24.84
2025-08-08 UBS Ashwani Verma $22 $36 +14 +46.9% $24.50
2025-06-26 Oppenheimer Matthew Hershenhorn $19 $22 +3 -2.4% $22.55
2025-05-20 Morgan Stanley Sean Laaman $20 $24 +4 +10.7% $21.69
2025-05-19 H.C. Wainwright Andrew Fein $27 $32 +5 +45.6% $21.98
2025-04-28 UBS $27 $22 -5 +50.1% $14.66
2025-01-03 Guggenheim Yatin Suneja $28 $20 -8 +8.2% $18.49
2024-08-07 Morgan Stanley Jeffrey Hung $18 $20 +2 +6.1% $18.85
2024-06-26 BMO Capital Keith Tapper Initiated $31 +100.0% $15.50
2024-05-09 H.C. Wainwright Andrew Fein $25 $27 +2 +57.6% $17.13
2024-05-09 Robert W. Baird Joel Beatty Initiated $28 +63.5% $17.13
2024-05-09 Mizuho Securities Uy Ear $19 $21 +2 +22.6% $17.13
2024-04-30 UBS Ashwani Verma $33 $27 -6 +57.9% $17.10
2024-03-12 UBS Ashwani Verma Initiated $33 +65.2% $19.98
2024-03-12 Oppenheimer Jay Olson $19 $19 0 -4.9% $19.98
2024-03-12 Needham Ami Fadia $37 $32 -5 +60.2% $19.98
2024-03-12 Canaccord Genuity Sumant Kulkami $31 $33 +2 +65.2% $19.98
2024-03-11 JMP Securities Jason Butler Initiated $39 +95.2% $19.98
2024-01-24 Needham Ami Fadia Initiated $37 +36.1% $27.19
2022-11-14 J.P. Morgan $34 $17 -17 +6.8% $15.92
2022-08-09 Morgan Stanley $22 $18 -4 +9.0% $16.51
2022-08-09 Mizuho Securities $27 $19 -8 +16.5% $16.31
2022-08-09 Goldman Sachs Initiated $15 -9.7% $16.62
2022-08-09 RBC Capital $26 $21 -5 +26.4% $16.62
2022-08-09 H.C. Wainwright $20 $25 +5 +50.4% $16.62
2022-08-09 Leerink Partners $27 $21 -6 +26.4% $16.62
2022-08-08 Cowen & Co. $32 $21 -11 +24.8% $16.83
2022-07-15 Morgan Stanley Initiated $22 +44.5% $15.23
2022-07-11 Leerink Partners $31 $27 -4 +71.5% $15.74
2022-06-22 Citigroup $32 $19 -13 +46.0% $13.01
2022-06-21 Oppenheimer $23 $19 -4 +51.3% $12.55
2022-06-21 Cantor Fitzgerald Initiated $26 +104.6% $12.71
2022-06-21 RBC Capital Initiated $26 +33.3% $19.51
2022-06-21 H.C. Wainwright $36 $20 -16 +2.5% $19.51
2022-04-19 Mizuho Securities Initiated $27 +23.9% $21.80
2022-03-19 Canaccord Genuity Sumant Kulkami Initiated $31 +22.1% $25.38
2022-02-28 Citigroup Neena Bitritto-Garg Initiated $32 +27.6% $25.07
2022-02-28 H.C. Wainwright Andrew Fein Initiated $36 +43.6% $25.07

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
1
ROE
5
ROA
5
D/E
3
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ACAD receives an overall rating of B+. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: DCF (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-04-01 A- B+
2026-03-24 B+ A-
2026-02-26 A- B+
2026-02-23 A A-
2026-02-20 A- A
2026-02-18 A A-
2026-01-03 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

63 Grade B
Profitability
61
Balance Sheet
97
Earnings Quality
24
Growth
68
Value
74
Momentum
61
Safety
100
Cash Flow
59
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ACAD scores highest in Safety (100/100) and lowest in Earnings Quality (24/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.74
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-1.04
Possible Manipulator
Ohlson O-Score
-10.70
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 94.2/100
Trend: Improving
Earnings Quality
25/100
OCF/NI: 0.33x
Accruals: 18.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ACAD scores 6.74, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ACAD scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ACAD's score of -1.04 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ACAD's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ACAD receives an estimated rating of AA+ (score: 94.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ACAD's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
9.58x
PEG
0.16x
P/S
3.30x
P/B
2.88x
P/FCF
18.10x
P/OCF
31.13x
EV/EBITDA
29.43x
EV/Revenue
2.81x
EV/EBIT
31.18x
EV/FCF
14.48x
Earnings Yield
9.77%
FCF Yield
5.53%
Shareholder Yield
0.00%
Graham Number
$18.65
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 9.6x earnings, ACAD trades at a deep value multiple. An earnings yield of 9.8% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $18.65 per share, 13% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
3.264
NI / EBT
×
Interest Burden
1.167
EBT / EBIT
×
EBIT Margin
0.090
EBIT / Rev
×
Asset Turnover
0.796
Rev / Assets
×
Equity Multiplier
1.404
Assets / Equity
=
ROE
38.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ACAD's ROE of 38.3% is driven by Asset Turnover (0.796), indicating efficient use of assets to generate revenue. A tax burden ratio of 3.26 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
59.34%
Fair P/E
127.17x
Intrinsic Value
$276.61
Price/Value
0.08x
Margin of Safety
91.95%
Premium
-91.95%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ACAD's realized 59.3% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $276.61, ACAD appears undervalued with a 92% margin of safety. The adjusted fair P/E of 127.2x compares to the current market P/E of 9.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$21.10
Median 1Y
$16.85
5th Pctile
$5.84
95th Pctile
$49.32
Ann. Volatility
62.5%
Analyst Target
$31.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
654
+9.4% YoY
Revenue / Employee
$1,464,521
Rev: $957,797,000
Profit / Employee
$346,255
NI: $226,451,000
SGA / Employee
$746,832
Avg labor cost proxy
R&D / Employee
$463,683
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -39.5% -28.9% -28.7% -36.7% -35.0% -37.2% -45.9% -31.0% -23.5% -31.6% -14.7% -0.4% 7.3% 30.9% 38.9% 39.3% 38.2% 44.9% 39.9% 38.3% 38.33%
ROA -33.4% -24.5% -22.6% -28.9% -27.6% -29.3% -33.5% -22.7% -17.2% -23.1% -9.2% -0.3% 4.6% 19.2% 23.4% 23.6% 22.9% 27.0% 28.4% 27.3% 27.30%
ROIC -4.7% -3.4% -1.6% -2.0% -1.9% -2.1% -3.9% -2.8% -2.2% -2.7% -1.2% 1.1% 30.4% 2.1% 7.0% 7.0% 6.8% 8.0% 64.2% 57.4% 57.41%
ROCE -38.9% -28.5% -28.2% -35.9% -34.2% -36.8% -48.4% -35.5% -27.6% -33.4% -14.8% -0.9% 4.6% 22.7% 10.6% 11.1% 11.4% 13.0% 9.5% 7.7% 7.67%
Gross Margin 95.5% 94.9% 98.0% 97.4% 98.0% 98.4% 98.2% 98.6% 95.5% 93.1% 92.3% 88.8% 92.5% 92.5% 91.6% 91.7% 92.2% 92.2% 90.8% 90.8% 90.75%
Operating Margin -37.9% -11.6% -34.2% -97.9% -25.0% -23.6% -33.7% -45.2% 1.8% -27.3% 15.1% 7.4% 12.6% 12.6% 59.1% 7.9% 12.2% 12.8% 6.1% -1.7% -1.72%
Net Margin -38.1% -11.0% -33.0% -97.9% -25.3% -20.8% -30.6% -36.3% 0.7% -30.8% 19.8% 8.0% 13.8% 13.1% 55.4% 7.8% 10.1% 25.8% 96.3% 1.4% 1.36%
EBITDA Margin -37.1% -10.9% -33.7% -97.4% -24.6% -23.2% -33.4% -44.9% 2.9% -26.5% 15.8% 10.1% 13.6% 12.6% 4.7% 9.1% 13.3% 17.1% 9.3% -1.7% -1.72%
FCF Margin -30.3% -28.1% -26.2% -28.8% -25.3% -22.2% -22.0% -10.7% -6.2% -14.7% 2.3% 7.8% 9.0% 21.8% 16.4% 5.0% 18.4% 18.9% 9.8% 19.4% 19.40%
OCF Margin -29.3% -27.4% -26.0% -28.8% -25.3% -22.2% -22.0% -10.7% -6.2% -14.6% 2.3% 7.8% 9.0% 21.8% 16.5% 15.0% 18.4% 19.0% 10.3% 11.3% 11.28%
ROE 3Y Avg snapshot only 20.48%
ROE 5Y Avg snapshot only -2.93%
ROA 3Y Avg snapshot only 14.35%
ROIC Economic snapshot only 20.99%
Cash ROA snapshot only 7.90%
Cash ROIC snapshot only 26.85%
CROIC snapshot only 46.19%
NOPAT Margin snapshot only 24.11%
Pretax Margin snapshot only 10.51%
R&D / Revenue snapshot only 29.89%
SGA / Revenue snapshot only 54.19%
SBC / Revenue snapshot only 2.51%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -14.95 -13.93 -22.37 -18.21 -11.13 -12.18 -11.94 -20.92 -35.67 -23.00 -85.07 -1801.67 88.35 19.89 13.48 12.17 16.38 13.94 11.71 10.23 9.578
P/S Ratio 8.44 5.63 7.76 7.92 4.45 5.18 4.99 5.87 7.18 5.42 7.18 3.79 3.03 2.75 3.19 2.80 3.57 3.48 4.27 3.51 3.299
P/B Ratio 6.24 4.26 6.94 7.22 4.21 4.90 6.44 7.63 9.87 8.55 12.07 7.14 6.25 5.92 4.17 3.80 4.97 4.97 3.73 3.13 2.883
P/FCF -27.83 -20.04 -29.61 -27.52 -17.57 -23.37 -22.61 -54.89 -115.20 -36.97 313.08 48.39 33.55 12.61 19.42 56.15 19.45 18.41 43.53 18.10 18.097
P/OCF 312.14 48.35 33.53 12.61 19.36 18.70 19.36 18.30 41.67 31.13 31.131
EV/EBITDA -12.80 -11.02 -19.74 -16.14 -8.93 -9.96 -10.04 -16.64 -28.95 -20.45 -71.24 444.75 67.65 17.83 24.07 21.00 28.94 25.04 28.99 29.43 29.428
EV/Revenue 7.19 4.40 6.81 6.99 3.55 4.28 4.30 5.19 6.53 4.86 6.65 3.32 2.60 2.34 2.45 2.09 2.88 2.81 3.56 2.81 2.809
EV/EBIT -12.64 -10.81 -19.35 -15.92 -8.82 -9.86 -9.95 -16.44 -28.23 -19.87 -65.85 -588.70 101.63 19.37 27.87 23.55 32.50 28.45 31.08 31.18 31.183
EV/FCF -23.69 -15.67 -26.02 -24.31 -14.05 -19.34 -19.50 -48.51 -104.86 -33.13 290.16 42.40 28.81 10.73 14.94 41.95 15.69 14.85 36.23 14.48 14.484
Earnings Yield -6.7% -7.2% -4.5% -5.5% -9.0% -8.2% -8.4% -4.8% -2.8% -4.3% -1.2% -0.1% 1.1% 5.0% 7.4% 8.2% 6.1% 7.2% 8.5% 9.8% 9.77%
FCF Yield -3.6% -5.0% -3.4% -3.6% -5.7% -4.3% -4.4% -1.8% -0.9% -2.7% 0.3% 2.1% 3.0% 7.9% 5.1% 1.8% 5.1% 5.4% 2.3% 5.5% 5.53%
PEG Ratio snapshot only 0.155
Price/Tangible Book snapshot only 3.437
EV/OCF snapshot only 24.916
EV/Gross Profit snapshot only 3.071
Acquirers Multiple snapshot only 38.031
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $18.65
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.77 6.77 6.43 6.43 6.43 6.43 4.04 4.04 4.04 4.04 2.42 2.42 2.42 2.42 2.38 2.38 2.38 2.38 3.83 3.83 3.833
Quick Ratio 6.68 6.68 6.35 6.35 6.35 6.35 3.99 3.99 3.99 3.99 2.28 2.28 2.28 2.28 2.32 2.32 2.32 2.32 3.71 3.71 3.708
Debt/Equity 0.08 0.08 0.12 0.12 0.12 0.12 0.15 0.15 0.15 0.15 0.13 0.13 0.13 0.13 0.07 0.07 0.07 0.07 0.04 0.04 0.043
Net Debt/Equity -0.93 -0.93 -0.84 -0.84 -0.84 -0.84 -0.89 -0.89 -0.89 -0.89 -0.88 -0.88 -0.88 -0.88 -0.96 -0.96 -0.96 -0.96 -0.63 -0.63 -0.625
Debt/Assets 0.06 0.06 0.09 0.09 0.09 0.09 0.11 0.11 0.11 0.11 0.08 0.08 0.08 0.08 0.04 0.04 0.04 0.04 0.03 0.03 0.033
Debt/EBITDA -0.19 -0.26 -0.39 -0.30 -0.32 -0.29 -0.28 -0.38 -0.50 -0.41 -0.84 9.43 1.67 0.47 0.53 0.52 0.51 0.44 0.40 0.50 0.499
Net Debt/EBITDA 2.24 3.08 2.73 2.13 2.24 2.07 1.60 2.19 2.85 2.37 5.63 -62.89 -11.14 -3.13 -7.21 -7.10 -6.94 -6.00 -5.84 -7.34 -7.340
Interest Coverage
Equity Multiplier 1.25 1.25 1.29 1.29 1.29 1.29 1.47 1.47 1.47 1.47 1.73 1.73 1.73 1.73 1.62 1.62 1.62 1.62 1.27 1.27 1.274
Cash Ratio snapshot only 2.958
Cash to Debt snapshot only 15.707
FCF to Debt snapshot only 4.071
Defensive Interval snapshot only 383.6 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.59 0.61 0.65 0.67 0.69 0.69 0.80 0.81 0.86 0.98 1.09 1.22 1.33 1.39 0.99 1.03 1.05 1.08 0.78 0.80 0.796
Inventory Turnover 2.50 2.73 2.18 1.98 1.69 1.17 1.40 1.22 1.88 3.60 1.96 2.96 3.47 3.67 2.83 2.74 2.83 2.93 3.14 3.30 3.299
Receivables Turnover 11.03 11.29 8.60 8.76 9.10 9.08 8.17 8.22 8.71 9.99 9.05 10.14 11.10 11.58 9.72 10.11 10.34 10.63 9.73 9.95 9.948
Payables Turnover 2.55 2.78 2.49 2.26 1.93 1.34 1.04 0.91 1.39 2.67 2.75 4.15 4.87 5.15 4.85 4.70 4.85 5.01 6.57 6.89 6.894
DSO 33 32 42 42 40 40 45 44 42 37 40 36 33 32 38 36 35 34 38 37 36.7 days
DIO 146 134 167 184 216 311 261 298 194 101 186 123 105 99 129 133 129 125 116 111 110.6 days
DPO 143 131 147 161 189 272 352 403 262 137 133 88 75 71 75 78 75 73 56 53 52.9 days
Cash Conversion Cycle 36 35 63 65 67 79 -47 -60 -26 1 94 71 63 60 91 91 89 86 98 94 94.4 days
Fixed Asset Turnover snapshot only 19.963
Operating Cycle snapshot only 147.3 days
Cash Velocity snapshot only 1.336
Capital Intensity snapshot only 1.428
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 17.9% 13.2% 9.6% 7.6% 10.6% 7.8% 6.8% 5.5% 7.5% 23.5% 40.4% 56.4% 61.7% 47.1% 31.8% 22.4% 14.4% 12.7% 11.9% 9.9% 9.93%
Net Income -16.2% 28.5% 40.4% 17.5% 21.8% -13.5% -28.7% 32.0% 45.8% 31.5% 71.6% 98.8% 1.3% 1.9% 4.7% 134.8% 6.3% 1.0% 72.7% 64.1% 64.12%
EPS -13.4% 29.6% 41.0% 18.1% 22.4% -12.6% -27.8% 32.4% 47.0% 32.5% 72.4% 98.9% 1.3% 1.9% 4.7% 134.0% 6.2% 97.9% 67.6% 59.3% 59.34%
FCF -1.4% 7.7% 11.8% 8.5% 7.8% 14.9% 10.1% 60.8% 73.5% 18.3% 1.1% 2.1% 3.3% 3.2% 8.4% -22.1% 1.3% -2.4% -33.1% 3.3% 3.28%
EBITDA -11.8% 30.7% 41.1% 18.0% 21.6% -16.3% -32.6% 24.1% 39.1% 31.9% 69.4% 1.0% 1.3% 1.8% 2.4% 15.3% 2.0% -3.8% 34.7% 5.5% 5.51%
Op. Income -12.0% 30.0% 40.5% 17.9% 21.6% -15.2% -31.2% 24.2% 38.3% 30.5% 67.2% 97.2% 1.2% 1.7% 4.1% 52.2% 9.4% 1.1% -54.6% -65.6% -65.55%
OCF Growth snapshot only -17.10%
Asset Growth snapshot only 31.69%
Equity Growth snapshot only 67.49%
Debt Growth snapshot only 0.37%
Shares Change snapshot only 3.00%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 35.8% 31.7% 29.3% 27.5% 24.7% 19.4% 15.1% 12.4% 11.9% 14.7% 18.0% 21.1% 24.3% 25.1% 25.5% 26.4% 25.7% 27.0% 27.5% 28.2% 28.17%
Revenue 5Y 3.9% 1.4% 94.6% 72.1% 52.1% 40.5% 32.9% 26.8% 24.4% 24.9% 26.6% 27.9% 27.5% 25.3% 23.1% 22.2% 21.0% 20.1% 19.4% 19.0% 19.04%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 37.8% 33.5% 31.3% 29.6% 26.7% 21.2% 16.6% 13.9% 13.0% 15.0% 17.6% 19.7% 22.6% 23.4% 23.5% 24.5% 23.5% 24.3% 24.7% 25.1% 25.13%
Gross Profit 5Y 79.9% 56.4% 43.8% 35.3% 28.7% 25.9% 26.1% 27.2% 28.0% 27.3% 24.8% 22.4% 21.5% 20.3% 19.3% 18.5% 18.0% 18.00%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 26.7% 26.7% 9.0% 9.0% 9.0% 9.0% -9.1% -9.1% -9.1% -9.1% -1.5% -1.5% -1.5% -1.5% 19.3% 19.3% 19.3% 19.3% 38.6% 38.6% 38.57%
Assets 5Y 28.7% 28.7% 4.5% 4.5% 4.5% 4.5% 8.9% 8.9% 8.9% 8.9% 6.8% 6.8% 6.8% 6.8% 8.7% 8.7% 8.7% 8.7% 14.9% 14.9% 14.85%
Equity 3Y 23.2% 23.2% 4.1% 4.1% 4.1% 4.1% -17.0% -17.0% -17.0% -17.0% -11.7% -11.7% -11.7% -11.7% 10.7% 10.7% 10.7% 10.7% 45.3% 45.3% 45.26%
Book Value 3Y 13.3% 13.3% -2.6% 0.3% 0.3% 0.6% -18.3% -18.1% -18.4% -18.0% -13.0% -12.9% -12.7% -12.7% 9.4% 9.2% 9.1% 8.7% 42.6% 42.3% 42.28%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 0.99 0.99 0.98 0.98 0.96 0.95 0.94 0.96 0.97 0.93 0.88 0.85 0.88 0.89 0.87 0.86 0.89 0.91 0.91 0.908
Earnings Stability 0.01 0.25 0.43 0.68 0.62 0.63 0.44 0.66 0.61 0.65 0.56 0.78 0.78 0.65 0.70 0.81 0.85 0.84 0.88 0.94 0.942
Margin Stability 0.00 0.00 0.00 0.91 0.95 0.96 0.97 0.97 0.98 0.98 0.98 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.969
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1
Earnings Persistence 0.94 0.89 0.84 0.93 0.91 0.95 0.89 0.87 0.82 0.87 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.00 0.32 0.47 0.51 0.514
ROE Trend 0.02 0.14 0.08 -0.02 -0.01 -0.06 -0.16 0.04 0.12 -0.02 0.28 0.38 0.40 0.68 0.65 0.50 0.41 0.39 0.24 0.15 0.152
Gross Margin Trend 0.02 0.01 0.01 0.01 0.02 0.03 0.02 0.02 0.01 -0.01 -0.03 -0.05 -0.06 -0.05 -0.05 -0.03 -0.03 -0.02 -0.01 -0.01 -0.007
FCF Margin Trend 0.23 0.16 0.13 0.07 0.08 0.09 0.07 0.21 0.22 0.10 0.26 0.28 0.25 0.40 0.26 0.06 0.17 0.15 0.00 0.13 0.130
Sustainable Growth Rate 7.3% 30.9% 38.9% 39.3% 38.2% 44.9% 39.9% 38.3% 38.33%
Internal Growth Rate 4.8% 23.8% 30.5% 31.0% 29.8% 36.9% 39.7% 37.6% 37.55%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.52 0.68 0.75 0.66 0.63 0.52 0.53 0.38 0.31 0.62 -0.27 -37.26 2.63 1.58 0.70 0.65 0.85 0.76 0.28 0.33 0.329
FCF/OCF 1.04 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.33 1.00 0.99 0.96 1.72 1.720
FCF/Net Income snapshot only 0.565
OCF/EBITDA snapshot only 1.181
CapEx/Revenue 1.0% 0.7% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 10.0% 0.1% 0.1% 0.4% 8.1% 8.12%
CapEx/Depreciation snapshot only 15.112
Accruals Ratio -0.16 -0.08 -0.06 -0.10 -0.10 -0.14 -0.16 -0.14 -0.12 -0.09 -0.12 -0.10 -0.07 -0.11 0.07 0.08 0.04 0.06 0.20 0.18 0.183
Sloan Accruals snapshot only 0.171
Cash Flow Adequacy snapshot only 1.389
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -1.1% -1.2% -0.5% -0.3% -0.5% -0.4% -0.3% -0.2% -0.2% -0.6% -0.5% -0.8% -0.8% -0.4% -0.2% -0.3% -0.6% -0.8% -1.1% -1.4% -1.36%
Total Shareholder Return -1.1% -1.2% -0.5% -0.3% -0.5% -0.4% -0.3% -0.2% -0.2% -0.6% -0.5% -0.8% -0.8% -0.4% -0.2% -0.3% -0.6% -0.8% -1.1% -1.4% -1.36%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.00 1.05 1.13 1.20 -0.11 0.67 0.94 0.88 0.86 0.83 0.95 2.81 3.26 3.264
Interest Burden (EBT/EBIT) 0.99 0.99 0.98 0.99 0.99 0.97 0.95 0.89 0.83 0.85 0.70 -3.25 2.00 1.22 3.06 3.00 2.97 2.65 1.13 1.17 1.167
EBIT Margin -0.57 -0.41 -0.35 -0.44 -0.40 -0.43 -0.43 -0.32 -0.23 -0.24 -0.10 -0.01 0.03 0.12 0.09 0.09 0.09 0.10 0.11 0.09 0.090
Asset Turnover 0.59 0.61 0.65 0.67 0.69 0.69 0.80 0.81 0.86 0.98 1.09 1.22 1.33 1.39 0.99 1.03 1.05 1.08 0.78 0.80 0.796
Equity Multiplier 1.18 1.18 1.27 1.27 1.27 1.27 1.37 1.37 1.37 1.37 1.61 1.61 1.61 1.61 1.66 1.66 1.66 1.66 1.40 1.40 1.404
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.63 $-1.19 $-1.04 $-1.33 $-1.27 $-1.34 $-1.33 $-0.90 $-0.67 $-0.91 $-0.37 $-0.01 $0.18 $0.77 $1.36 $1.37 $1.32 $1.53 $2.28 $2.18 $2.18
Book Value/Share $3.91 $3.90 $3.36 $3.35 $3.35 $3.34 $2.47 $2.47 $2.43 $2.44 $2.59 $2.59 $2.60 $2.60 $4.40 $4.37 $4.34 $4.29 $7.16 $7.11 $7.32
Tangible Book/Share $3.90 $3.90 $3.36 $3.35 $3.35 $3.34 $2.47 $2.47 $2.43 $2.44 $2.20 $2.20 $2.20 $2.20 $3.68 $3.66 $3.63 $3.59 $6.53 $6.48 $6.48
Revenue/Share $2.89 $2.95 $3.01 $3.06 $3.17 $3.16 $3.19 $3.21 $3.34 $3.85 $4.36 $4.88 $5.36 $5.59 $5.76 $5.94 $6.04 $6.14 $6.25 $6.34 $6.42
FCF/Share $-0.88 $-0.83 $-0.79 $-0.88 $-0.80 $-0.70 $-0.70 $-0.34 $-0.21 $-0.56 $0.10 $0.38 $0.48 $1.22 $0.94 $0.30 $1.11 $1.16 $0.61 $1.23 $1.25
OCF/Share $-0.85 $-0.81 $-0.78 $-0.88 $-0.80 $-0.70 $-0.70 $-0.34 $-0.21 $-0.56 $0.10 $0.38 $0.48 $1.22 $0.95 $0.89 $1.11 $1.17 $0.64 $0.72 $0.72
Cash/Share $3.94 $3.93 $3.24 $3.23 $3.22 $3.22 $2.57 $2.57 $2.53 $2.54 $2.64 $2.63 $2.64 $2.64 $4.54 $4.51 $4.48 $4.43 $4.78 $4.75 $4.99
EBITDA/Share $-1.62 $-1.18 $-1.04 $-1.33 $-1.26 $-1.36 $-1.37 $-1.00 $-0.75 $-0.91 $-0.41 $0.04 $0.21 $0.73 $0.59 $0.59 $0.60 $0.69 $0.77 $0.61 $0.61
Debt/Share $0.31 $0.31 $0.40 $0.40 $0.40 $0.40 $0.38 $0.38 $0.38 $0.38 $0.34 $0.34 $0.34 $0.34 $0.31 $0.31 $0.31 $0.30 $0.30 $0.30 $0.30
Net Debt/Share $-3.63 $-3.63 $-2.84 $-2.83 $-2.82 $-2.82 $-2.19 $-2.19 $-2.15 $-2.16 $-2.29 $-2.29 $-2.30 $-2.30 $-4.23 $-4.20 $-4.17 $-4.13 $-4.48 $-4.44 $-4.44
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 6.736
Altman Z-Prime snapshot only 11.922
Piotroski F-Score 3 3 4 4 4 3 3 4 3 3 5 5 6 6 6 5 4 4 5 5 5
Beneish M-Score -3.03 -2.61 -2.08 -2.28 -2.30 -2.51 -3.23 -3.16 -2.96 -2.59 -1.30 -1.18 -1.24 -1.47 -1.80 -1.76 -1.95 -1.81 -0.93 -1.04 -1.041
Ohlson O-Score snapshot only -10.703
ROIC (Greenblatt) snapshot only 11.75%
Net-Net WC snapshot only $4.20
EVA snapshot only $218045470.31
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA+
Credit Score 74.02 73.71 74.12 74.77 75.45 75.48 71.46 76.20 76.41 76.48 81.85 62.08 80.14 84.98 88.60 84.81 90.98 90.96 94.41 94.24 94.245
Credit Grade snapshot only 2
Credit Trend snapshot only 9.433
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 93
Sector Credit Rank snapshot only 88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms